Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Co-occurring Chronic Conditions and Economic Burden among Stroke Survivors in the United States: A Propensity Score-Matched Analysis.

Chinthammit C, Coull BM, Nimworapan M, Bhattacharjee S.

J Stroke Cerebrovasc Dis. 2017 Feb;26(2):393-402. doi: 10.1016/j.jstrokecerebrovasdis.2016.09.040. Epub 2016 Oct 25.

PMID:
27793537
2.

Tissue-Negative Transient Ischemic Attack: Is There a Role for Perfusion MRI?

Grams RW, Kidwell CS, Doshi AH, Drake K, Becker J, Coull BM, Nael K.

AJR Am J Roentgenol. 2016 Jul;207(1):157-62. doi: 10.2214/AJR.15.15447. Epub 2016 Apr 12.

PMID:
27070836
3.

Objective fall risk detection in stroke survivors using wearable sensor technology: a feasibility study.

Taylor-Piliae RE, Mohler MJ, Najafi B, Coull BM.

Top Stroke Rehabil. 2016 Dec;23(6):393-399. Epub 2016 Mar 15.

PMID:
26382725
4.

Six-minute magnetic resonance imaging protocol for evaluation of acute ischemic stroke: pushing the boundaries.

Nael K, Khan R, Choudhary G, Meshksar A, Villablanca P, Tay J, Drake K, Coull BM, Kidwell CS.

Stroke. 2014 Jul;45(7):1985-91. doi: 10.1161/STROKEAHA.114.005305. Epub 2014 Jun 10.

PMID:
24916906
5.

Effect of Tai Chi on physical function, fall rates and quality of life among older stroke survivors.

Taylor-Piliae RE, Hoke TM, Hepworth JT, Latt LD, Najafi B, Coull BM.

Arch Phys Med Rehabil. 2014 May;95(5):816-24. doi: 10.1016/j.apmr.2014.01.001. Epub 2014 Jan 17.

PMID:
24440643
6.

Healthcare utilization of patients with epilepsy in Yuma County, Arizona: do disparities exist?

Sim Y, Nokes B, Byreddy S, Chong J, Coull BM, Labiner DM.

Epilepsy Behav. 2014 Feb;31:307-11. doi: 10.1016/j.yebeh.2013.10.018. Epub 2013 Nov 5.

PMID:
24210458
7.

Comment: Natriuretic peptides as predictive biomarkers of stroke outcome.

Coull BM.

Neurology. 2013 Dec 3;81(23):1983. doi: 10.1212/01.wnl.0000436941.55281.9c. Epub 2013 Nov 1. No abstract available.

PMID:
24186913
8.

Quantitative analysis of hypoperfusion in acute stroke: arterial spin labeling versus dynamic susceptibility contrast.

Nael K, Meshksar A, Liebeskind DS, Coull BM, Krupinski EA, Villablanca JP.

Stroke. 2013 Nov;44(11):3090-6. doi: 10.1161/STROKEAHA.113.002377. Epub 2013 Aug 29.

9.

Strategies to improve recruitment and retention of older stroke survivors to a randomized clinical exercise trial.

Taylor-Piliae RE, Boros D, Coull BM.

J Stroke Cerebrovasc Dis. 2014 Mar;23(3):462-8. doi: 10.1016/j.jstrokecerebrovasdis.2013.03.031. Epub 2013 May 2.

PMID:
23643477
10.

Predictors of depressive symptoms among community-dwelling stroke survivors.

Taylor-Piliae RE, Hepworth JT, Coull BM.

J Cardiovasc Nurs. 2013 Sep-Oct;28(5):460-7. doi: 10.1097/JCN.0b013e318258ad57.

PMID:
22710739
11.

Predictors of gait velocity among community-dwelling stroke survivors.

Taylor-Piliae RE, Latt LD, Hepworth JT, Coull BM.

Gait Posture. 2012 Mar;35(3):395-9. doi: 10.1016/j.gaitpost.2011.10.358. Epub 2011 Nov 26.

12.

Transcobalamin 2 variant associated with poststroke homocysteine modifies recurrent stroke risk.

Hsu FC, Sides EG, Mychaleckyj JC, Worrall BB, Elias GA, Liu Y, Chen WM, Coull BM, Toole JF, Rich SS, Furie KL, Sale MM.

Neurology. 2011 Oct 18;77(16):1543-50. doi: 10.1212/WNL.0b013e318233b1f9. Epub 2011 Oct 5.

13.

Community-based Yang-style Tai Chi is safe and feasible in chronic stroke: a pilot study.

Taylor-Piliae RE, Coull BM.

Clin Rehabil. 2012 Feb;26(2):121-31. doi: 10.1177/0269215511419381. Epub 2011 Sep 21.

PMID:
21937523
14.

Clinical research training opportunities and elements.

Franz D, Coull BM.

Front Neurol Neurosci. 2009;25:203-205. doi: 10.1159/000209502. Epub 2009 Mar 19. No abstract available.

PMID:
19478524
15.

Phase I/II--design and analysis.

Coleman WP, Woodbury-Harris KM, Coull BM.

Front Neurol Neurosci. 2009;25:52-54. doi: 10.1159/000209474. Epub 2009 Mar 19. No abstract available.

PMID:
19478496
16.

Frontiers of neurology and neuroscience. Clinical trials in the neurosciences. Introduction.

Coull BM, Woodbury-Harris KM.

Front Neurol Neurosci. 2009;25:1-3. doi: 10.1159/000209467. Epub 2009 Mar 17. No abstract available.

PMID:
19478490
17.

Statins: not just for the young or the faint of heart.

Coull BM, Johnston SC.

Neurology. 2009 Feb 24;72(8):684-5. doi: 10.1212/01.wnl.0000344641.78835.08. No abstract available.

PMID:
19237695
18.

Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial.

Bruno A, Kent TA, Coull BM, Shankar RR, Saha C, Becker KJ, Kissela BM, Williams LS.

Stroke. 2008 Feb;39(2):384-9. Epub 2007 Dec 20.

PMID:
18096840
19.

The initial acute phase response predicts long-term stroke recovery.

Clark WM, Beamer NB, Wynn M, Coull BM.

J Stroke Cerebrovasc Dis. 1998 Mar-Apr;7(2):128-31.

PMID:
17895069
20.

Aphasia severity: Association with cerebral perfusion and diffusion.

Fridriksson J, Holland AL, Coull BM, Plante E, Trouard TP, Beeson P.

Aphasiology. 2002 Sep 1;16(9):859-871.

21.

Leukocyte-platelet aggregates in rat peripheral blood after ischemic stroke and reperfusion.

Ritter LS, Stempel KM, Coull BM, McDonagh PF.

Biol Res Nurs. 2005 Apr;6(4):281-8.

PMID:
15788737
22.

Statin therapy after acute ischemic stroke in the heart protection study: is the role in recurrent stroke prevention now defined?

Coull BM.

Stroke. 2004 Sep;35(9):2233-4. Epub 2004 Jul 22. Review. No abstract available.

PMID:
15272131
23.

Parathyroid hormone-related protein induction in focal stroke: a neuroprotective vascular peptide.

Funk JL, Migliati E, Chen G, Wei H, Wilson J, Downey KJ, Mullarky PJ, Coull BM, McDonagh PF, Ritter LS.

Am J Physiol Regul Integr Comp Physiol. 2003 Apr;284(4):R1021-30. Epub 2002 Nov 27.

24.

Potassium depletion as a risk factor for stroke: will a banana a day keep your stroke away?

Levine SR, Coull BM.

Neurology. 2002 Aug 13;59(3):302-3. No abstract available.

PMID:
12177360
25.

Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association).

Coull BM, Williams LS, Goldstein LB, Meschia JF, Heitzman D, Chaturvedi S, Johnston KC, Starkman S, Morgenstern LB, Wilterdink JL, Levine SR, Saver JL; Joint Stroke Guideline Development Committee of the American Academy of Neurology; American Stroke Association.

Stroke. 2002 Jul;33(7):1934-42. Review. No abstract available.

PMID:
12105379
26.

Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association).

Coull BM, Williams LS, Goldstein LB, Meschia JF, Heitzman D, Chaturvedi S, Johnston KC, Starkman S, Morgenstern LB, Wilterdink JL, Levine SR, Saver JL; American Academy of Neurology; American Stroke Association.

Neurology. 2002 Jul 9;59(1):13-22. No abstract available.

PMID:
12105302
27.

Protective effects of inhibiting both blood and vascular selectins after stroke and reperfusion.

Ruehl ML, Orozco JA, Stoker MB, McDonagh PF, Coull BM, Ritter LS.

Neurol Res. 2002 Apr;24(3):226-32.

PMID:
11958413
28.
29.

Leukocyte accumulation and hemodynamic changes in the cerebral microcirculation during early reperfusion after stroke.

Ritter LS, Orozco JA, Coull BM, McDonagh PF, Rosenblum WI.

Stroke. 2000 May;31(5):1153-61.

PMID:
10797180
30.

Role of a common mutation in the homocysteine regulatory enzyme methylenetetrahydrofolate reductase in ischemic stroke.

Press RD, Beamer N, Evans A, DeLoughery TG, Coull BM.

Diagn Mol Pathol. 1999 Mar;8(1):54-8.

PMID:
10408794
31.

Microalbuminuria in ischemic stroke.

Beamer NB, Coull BM, Clark WM, Wynn M.

Arch Neurol. 1999 Jun;56(6):699-702.

PMID:
10369309
32.

Cognitive impairment and intracranial calcification in chronic hypoparathyroidism.

Kowdley KV, Coull BM, Orwoll ES.

Am J Med Sci. 1999 May;317(5):273-7.

PMID:
10334112
33.

Persistent inflammatory response in stroke survivors.

Beamer NB, Coull BM, Clark WM, Briley DP, Wynn M, Sexton G.

Neurology. 1998 Jun;50(6):1722-8.

PMID:
9633717
34.

Cerebral venous thrombosis. Role of activated protein C resistance and factor V gene mutation.

Brey RL, Coull BM.

Stroke. 1996 Oct;27(10):1719-20. No abstract available.

PMID:
8841316
35.

Randomized trial of Cervene, a kappa receptor-selective opioid antagonist, in acute ischemic stroke.

Clark WM, Coull BM, Karukin M, Hendin B, Kelley R, Rosing H, Zachariah S, Winograd M, Raps E, Walshe T, Singer S, Mettinger KL.

J Stroke Cerebrovasc Dis. 1996 Sep-Oct;6(1):35-40.

PMID:
17894963
36.

The many windows of therapeutic opportunities in stroke.

Coull BM.

Curr Opin Neurol. 1996 Feb;9(1):43-5. Review. No abstract available.

PMID:
8722663
37.
38.

Time course of ICAM-1 expression and leukocyte subset infiltration in rat forebrain ischemia.

Clark WM, Lauten JD, Lessov N, Woodward W, Coull BM.

Mol Chem Neuropathol. 1995 Dec;26(3):213-30.

PMID:
8748925
39.

Lazaroids. CNS pharmacology and current research.

Clark WM, Hazel JS, Coull BM.

Drugs. 1995 Dec;50(6):971-83. Review.

PMID:
8612475
40.

Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis.

Clark WM, Barnwell SL, Nesbit G, O'Neill OR, Wynn ML, Coull BM.

Stroke. 1995 Jul;26(7):1200-4.

PMID:
7604414
41.

Interleukin-6 and interleukin-1 receptor antagonist in acute stroke.

Beamer NB, Coull BM, Clark WM, Hazel JS, Silberger JR.

Ann Neurol. 1995 Jun;37(6):800-5.

PMID:
7778854
42.

Cytokine and superoxide production in clinical stroke.

Clark WM, Lauten JD, Beamer NB, Coull BM.

J Stroke Cerebrovasc Dis. 1995;5(3):166-71. doi: 10.1016/S1052-3057(10)80169-7. Epub 2010 Jun 10.

PMID:
26486814
43.

The influence of antiadhesion therapies on leukocyte subset accumulation in central nervous system ischemia in rats.

Clark WM, Lauten JD, Lessov N, Woodward W, Coull BM.

J Mol Neurosci. 1995;6(1):43-50.

PMID:
8562319
44.

Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke.

Barnwell SL, Clark WM, Nguyen TT, O'Neill OR, Wynn ML, Coull BM.

AJNR Am J Neuroradiol. 1994 Nov;15(10):1817-22.

PMID:
7863929
45.

Spontaneous echo contrast and hemorheologic abnormalities in cerebrovascular disease.

Briley DP, Giraud GD, Beamer NB, Spear EM, Grauer SE, Edwards JM, Clark WM, Sexton GJ, Coull BM.

Stroke. 1994 Aug;25(8):1564-9.

PMID:
7518970
46.

Therapeutic efficacy of tirilazad in experimental multiple cerebral emboli: a randomized, controlled trial.

Clark WM, Hotan T, Lauten JD, Coull BM.

Crit Care Med. 1994 Jul;22(7):1161-6.

PMID:
8026207
47.

Reduction of central nervous system reperfusion injury in rabbits using doxycycline treatment.

Clark WM, Calcagno FA, Gabler WL, Smith JR, Coull BM.

Stroke. 1994 Jul;25(7):1411-5; discussion 1416.

PMID:
8023357
48.

Childhood stroke and lupus anticoagulant.

Olson JC, Konkol RJ, Gill JC, Dobyns WB, Coull BM.

Pediatr Neurol. 1994 Feb;10(1):54-7.

PMID:
8198673
49.

Need for treatment of elevated plasma fibrinogen levels in cerebrovascular disease.

Clark WM, Coull BM, Beamer NB.

Heart Dis Stroke. 1993 Nov-Dec;2(6):503-6. Review. No abstract available.

PMID:
8137058
50.

Fibrinogen and the albumin-globulin ratio in recurrent stroke.

Beamer N, Coull BM, Sexton G, de Garmo P, Knox R, Seaman G.

Stroke. 1993 Aug;24(8):1133-9.

PMID:
8342186

Supplemental Content

Loading ...
Support Center